Raymond James & Associates T2 Biosystems, Inc. Transaction History

Raymond James & Associates

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$0.09 - $565.0 $1,440 - $9.04 Million	-16,000 Reduced 40.0%	24,000 $3,000
Q4 2021 Feb 08, 2022	BUY	$0.46 - $0.94 $1,288 - $2,632	2,800 Added 7.53%	40,000 $21,000
Q2 2021 Aug 11, 2021	BUY	$1.04 - $1.69 $5,200 - $8,450	5,000 Added 15.53%	37,200 $44,000
Q1 2021 May 14, 2021	BUY	$1.32 - $3.79 $42,504 - $122,038	32,200 New	32,200 $52,000
Q3 2019 Nov 07, 2019	SELL	$0.58 - $3.01 $27,462 - $142,523	-47,350 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$1.47 - $3.16 $33,075 - $71,100	22,500 Added 90.54%	47,350 $80,000
Q1 2019 May 06, 2019	BUY	$2.56 - $4.48 $63,616 - $111,328	24,850 New	24,850 $65,000
Q3 2018 Nov 14, 2018	SELL	$5.36 - $7.83 $69,374 - $101,343	-12,943 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$5.97 - $9.58 $77,269 - $123,993	12,943 New	12,943 $100,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $15.9M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.